US 12128090
Methods of prophylactic treatment using recombinant VWF (rVWF)
granted A61KA61K38/36A61K38/37
Quick answer
US patent 12128090 (Methods of prophylactic treatment using recombinant VWF (rVWF)) held by Takeda Pharmaceutical Company Limited expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K38/36, A61K38/37, A61K9/0019, A61P